FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4290546510> ?p ?o ?g. }

• W4290546510 abstract "Background Type 2 diabetes leads to an increase in the prevalence of lipid abnormalities, which increases the risk of cardiovascular disease. Therefore, current guidelines generally recommend the use of moderate or high-intensity statins in patients with type 2 diabetes. There are still few studies on the overall risk benefit balance of statins for acute myocardial infarction (AMI) patients with diabetes. Compared with other types of lipid-lowering drugs, the advantage of statins for the prognosis of patients with AMI has not yet been determined. We investigated the effects of statins and non-statins on intensive care unit (ICU) and inpatient mortality in patients with AMI and diabetes. Methods This study retrospectively collected all patients with AMI and diabetes in the Medical Information Mart Intensive Care-IV database. We assessed ICU and in-hospital mortality rates during hospitalization in both groups. The clinical end point was in-hospital mortality and ICU mortality. Kaplan-Meier and Cox proportional-hazards regression models were applied to analyze the correlation between the two groups and the outcomes. Results Data on 1,315 patients with AMI and diabetes were collected, among which 1,211 used statins during hospitalization. The overall in-hospital mortality of patients with AMI and diabetes was 17.2%, and the total ICU mortality was 12.6%. The in-hospital mortality was lower for the statin group than for the non-statin group (13.9% and 55.8%, respectively). Kaplan-Meier survival curves demonstrated that survival probability was higher in the statin group than in the non-statin group. In the cohort without hyperlipidemia, the statin group had lower risks of ICU death (HR = 0.12, 95% CI = 0.04–0.40) and in-hospital death (HR = 0.36, 95% CI = 0.16–0.84) compared with the non-statin group. Conclusions Statins can significantly reduce ICU and in-hospital mortality rates in patients with AMI and diabetes. Even in the population without hyperlipidemia, statins can still reduce the mortality in patients with AMI and diabetes." @default.
• W4290546510 created "2022-08-08" @default.
• W4290546510 creator A5002418737 @default.
• W4290546510 creator A5031755593 @default.
• W4290546510 creator A5044477564 @default.
• W4290546510 creator A5055470393 @default.
• W4290546510 creator A5057743730 @default.
• W4290546510 creator A5068019245 @default.
• W4290546510 creator A5079622715 @default.
• W4290546510 creator A5087069326 @default.
• W4290546510 date "2022-08-08" @default.
• W4290546510 modified "2023-10-14" @default.
• W4290546510 title "Association between statin use and the prognosis of patients with acute myocardial infarction complicated with diabetes" @default.
• W4290546510 cites W1816597323 @default.
• W4290546510 cites W1856460279 @default.
• W4290546510 cites W1965952643 @default.
• W4290546510 cites W1997485108 @default.
• W4290546510 cites W2008019394 @default.
• W4290546510 cites W2053365438 @default.
• W4290546510 cites W2070970918 @default.
• W4290546510 cites W2072145747 @default.
• W4290546510 cites W2096210401 @default.
• W4290546510 cites W2101508556 @default.
• W4290546510 cites W2120986848 @default.
• W4290546510 cites W2138299718 @default.
• W4290546510 cites W2150959326 @default.
• W4290546510 cites W2153729286 @default.
• W4290546510 cites W217155269 @default.
• W4290546510 cites W2200285648 @default.
• W4290546510 cites W2524053332 @default.
• W4290546510 cites W2748868481 @default.
• W4290546510 cites W2789251847 @default.
• W4290546510 cites W2900034165 @default.
• W4290546510 cites W2909249787 @default.
• W4290546510 cites W2953804067 @default.
• W4290546510 cites W3034853614 @default.
• W4290546510 cites W3113073503 @default.
• W4290546510 cites W3126983781 @default.
• W4290546510 cites W3129818723 @default.
• W4290546510 cites W3183857127 @default.
• W4290546510 cites W3187536395 @default.
• W4290546510 cites W4254135372 @default.
• W4290546510 doi "https://doi.org/10.3389/fcvm.2022.976656" @default.
• W4290546510 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36003903" @default.
• W4290546510 hasPublicationYear "2022" @default.
• W4290546510 type Work @default.
• W4290546510 citedByCount "0" @default.
• W4290546510 crossrefType "journal-article" @default.
• W4290546510 hasAuthorship W4290546510A5002418737 @default.
• W4290546510 hasAuthorship W4290546510A5031755593 @default.
• W4290546510 hasAuthorship W4290546510A5044477564 @default.
• W4290546510 hasAuthorship W4290546510A5055470393 @default.
• W4290546510 hasAuthorship W4290546510A5057743730 @default.
• W4290546510 hasAuthorship W4290546510A5068019245 @default.
• W4290546510 hasAuthorship W4290546510A5079622715 @default.
• W4290546510 hasAuthorship W4290546510A5087069326 @default.
• W4290546510 hasBestOaLocation W42905465101 @default.
• W4290546510 hasConcept C126322002 @default.
• W4290546510 hasConcept C134018914 @default.
• W4290546510 hasConcept C177713679 @default.
• W4290546510 hasConcept C179755657 @default.
• W4290546510 hasConcept C194828623 @default.
• W4290546510 hasConcept C2776376669 @default.
• W4290546510 hasConcept C2776839432 @default.
• W4290546510 hasConcept C2777180221 @default.
• W4290546510 hasConcept C2777984932 @default.
• W4290546510 hasConcept C2779134260 @default.
• W4290546510 hasConcept C500558357 @default.
• W4290546510 hasConcept C50382708 @default.
• W4290546510 hasConcept C555293320 @default.
• W4290546510 hasConcept C71924100 @default.
• W4290546510 hasConceptScore W4290546510C126322002 @default.
• W4290546510 hasConceptScore W4290546510C134018914 @default.
• W4290546510 hasConceptScore W4290546510C177713679 @default.
• W4290546510 hasConceptScore W4290546510C179755657 @default.
• W4290546510 hasConceptScore W4290546510C194828623 @default.
• W4290546510 hasConceptScore W4290546510C2776376669 @default.
• W4290546510 hasConceptScore W4290546510C2776839432 @default.
• W4290546510 hasConceptScore W4290546510C2777180221 @default.
• W4290546510 hasConceptScore W4290546510C2777984932 @default.
• W4290546510 hasConceptScore W4290546510C2779134260 @default.
• W4290546510 hasConceptScore W4290546510C500558357 @default.
• W4290546510 hasConceptScore W4290546510C50382708 @default.
• W4290546510 hasConceptScore W4290546510C555293320 @default.
• W4290546510 hasConceptScore W4290546510C71924100 @default.
• W4290546510 hasLocation W42905465101 @default.
• W4290546510 hasLocation W42905465102 @default.
• W4290546510 hasLocation W42905465103 @default.
• W4290546510 hasOpenAccess W4290546510 @default.
• W4290546510 hasPrimaryLocation W42905465101 @default.
• W4290546510 hasRelatedWork W2051784511 @default.
• W4290546510 hasRelatedWork W2071303398 @default.
• W4290546510 hasRelatedWork W2273167210 @default.
• W4290546510 hasRelatedWork W2367140913 @default.
• W4290546510 hasRelatedWork W2534023429 @default.
• W4290546510 hasRelatedWork W2599476257 @default.
• W4290546510 hasRelatedWork W2973263109 @default.
• W4290546510 hasRelatedWork W3037387124 @default.
• W4290546510 hasRelatedWork W3198402806 @default.
• W4290546510 hasRelatedWork W4386328149 @default.

• next